Veterinary preparations.

Veterinary preparations.

Pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for injection for the treatment of tumours; pharmaceutical preparations for injection for the treatment of carcinoid tumours; pharmaceutical preparations for injection comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for injection for gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of esophageal bleeding; pharmaceutical preparations for injection for metabolic disorders; pharmaceutical preparations for injection for the treatment of acromegaly; pharmaceutical preparations for injection for the treatment of polycystic liver disease; pharmaceutical preparations for injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone; Pharmaceutical preparations for subcutaneous injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for subcutaneous injection for the treatment of tumours; pharmaceutical preparations for subcutaneous injection for the treatment of carcinoid tumours; pharmaceutical preparations for subcutaneous injection comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for subcutaneous injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for subcutaneous injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for subcutaneous injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for subcutaneous injection for gastrointestinal bleeding disorders; pharmaceutical preparations for subcutaneous injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for subcutaneous injection for the treatment of esophageal bleeding; pharmaceutical preparations for subcutaneous injection for metabolic disorders; pharmaceutical preparations for subcutaneous injection for the treatment of acromegaly; pharmaceutical preparations for subcutaneous injection for the treatment of polycystic liver disease; pharmaceutical preparations for subcutaneous injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for subcutaneous injection intended to block growth hormone; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for the treatment of neuroendocrine tumours; pharmaceutical preparations for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of esophageal bleeding; pharmaceutical preparations for metabolic disorders; pharmaceutical preparations for the treatment of acromegaly; pharmaceutical preparations for the treatment of polycystic liver disease; pharmaceutical preparations for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for the treatment of respiratory distress syndrome; pharmaceutical preparations for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations intended to block growth hormone

Autoinjectors for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; autoinjectors for administration of pharmaceuticals for the treatment of tumours; autoinjectors for administration of pharmaceuticals for the treatment of carcinoid tumours; autoinjectors for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; autoinjectors for administration of pharmaceuticals for the treatment of neuroendocrine tumours; autoinjectors for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; autoinjectors for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; autoinjectors for administration of pharmaceuticals for gastrointestinal bleeding disorders; autoinjectors for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; autoinjectors for administration of pharmaceuticals for the treatment of esophageal bleeding; autoinjectors for administration of pharmaceuticals for metabolic disorders; autoinjectors for administration of pharmaceuticals for the treatment of acromegaly; autoinjectors for administration of pharmaceuticals for the treatment of polycystic liver disease; autoinjectors for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; autoinjectors for administration of pharmaceuticals for the treatment of respiratory distress syndrome; autoinjectors for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; autoinjectors for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; autoinjectors for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; pens for administration of pharmaceuticals for the treatment of tumours; pens for administration of pharmaceuticals for the treatment of carcinoid tumours; pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of esophageal bleeding; pens for administration of pharmaceuticals for metabolic disorders; pens for administration of pharmaceuticals for the treatment of acromegaly; pens for administration of pharmaceuticals for the treatment of polycystic liver disease; pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; pens for administration of pharmaceuticals intended to block growth hormone; devices for subcutaneous administration of pharmaceuticals; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; pens for subcutaneous administration of pharmaceuticals; pens for parenteral administration of pharmaceuticals; pens for injection of pharmaceutical depots; pens for subcutaneous injection of pharmaceutical depot; pens for parenteral injection of pharmaceutical depot; pens for injection of injection fluids; pens for injection of injection depot; pens for injections; pens for medical uses

Electric flashlights; electric lamps; head torches; lanterns for lighting; lighting fixtures; outdoor lighting fixtures; penlights; pocket torches, electric; portable headlamps; reading lights; rechargeable flashlights; table lamps

Lasers and integrated lasers not for medical use; integrated optical circuits; optical equipment, in the nature of sub-systems and modules comprised of optical lasers, filters, detectors, receivers, transmitters, modulators, choppers, optic mounts, prism mounts, top mounts, fiber aligners, multi-axis stages, translation stages, beam pick-offs, polarizing beamsplitter cubes, neutral density filters, aspheric lenses, ultraviolet excimer mirrors, dielectric mirrors, IR sensor cards, metal mirrors, neutral density mirrors, optic polarizers, sheet polarizers, and variable wave plates; fiber optic transceivers; fiber optic switching apparatus; wavelength selective switches; fiber optic coupling apparatus; custom designed optical chips; opto-electronic devices, namely, phase and amplitude modulators, modulator drivers, and high-voltage amplifiers; optical waveguides; optical communication systems comprised of electronic and fiber-optics hardware components; sensors, namely, high-speed photodetectors; gyroscopes and distance measuring apparatus, namely, test and measurement non-medical tunable lasers; laser diodes, non-medical lasers, namely, tunable lasers; industrial lasers, communications lasers, lasers for use in printers; optical modulators, optical amplifiers; erbium doped fiber amplifiers (EDFAs), optical receivers, transmitters, transponders and transceivers; field effect transistors (FETs), monolithic microwave integrated circuits (MMICs); receivers, namely, optical and electrical receivers; optical modulators, amplifiers, and repeaters, multiplexers, demultiplexers, add-drop multiplexers, fixed and reconfigurable optical add/drop modules, photodiodes, p-i-n diodes, avalanche photodiodes, optical filters, filters in the form of color sequencing wheels, thin-film filters for optical devices; microwave RF devices for transmitting and receiving radio waves, opto-mechanical devices, namely, optical choppers. optical laboratory equipment, namely, beam pick-offs, polarizing beamsplitter cubes, neutral-density filters, aspheric lenses, UV excimer and dielectric mirrors, polarizers and wave plates. optical spectrometers, optical spectroscopy equipment in the nature of non-medical lasers, namely, fixed-wavelength violet, blue, green and red lasers; computers and computer software for use in operating all of the above, as well as operating semiconductor manufacturing machines, precision mechanical machines, precision positions machines, and medical and non-medical lasers; precision mechanical devices, namely, optical amplifiers and pump diodes for optical communications networks, transmitters, transceivers, receivers and thin- film filters for use with optical networks; high power laser diodes for solid state and fiber laser pumping, material process and biotechnology applications, and photonics tools, optics, optical filters and detectors; optical interferometers; optical attenuators; optical temperature sensors, optical chemical sensors; biological sensors; advanced fiber-optic components and subsystem, namely, dense wavelength division multiplexers, dense wavelength wavelength division de-multiplexers and tunable chromatic dispersion compensators, for use in photonic network applications, namely, the transmission of multiple signals and compensation of chromatic dispersion through and in optical fiber communications systems; Optical communications and data networking hardware, namely, optical hardware used for fiber optic transmission; structural and replacement parts for all of the aforesaid goods

Abreuvoir pour animaux, mis eu point.

Oil-absorbent peat.